Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Skin Neoplasms 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 12aldesleukin 9fludarabine 8fludarabine phosphate 7pembrolizumab 6Ipilimumab 5Interleukin-2 5Nivolumab 4dabrafenib 2Vemurafenib 2Biopsy 2Aminolevulinic Acid 2varlilumab 1trametinib 1tilsotolimod 1spartalizumab 1sotigalimab 1sonidegib 1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1glembatumumab vedotin 1eprenetapopt 1epacadostat 1encorafenib 1cemiplimab 1cabozantinib 1binimetinib 1bempegaldesleukin 1abobotulinumtoxinA 1X-Rays 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Skin Neoplasms × In Situ Hybridization × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡